The distribution of fibronectin, an extra-
Fibronectin encompasses a family of high molecular weight adhesive glycoproteins which are widely distributed in the extracellular matrix and tissue fluids, including plasma. Different molecular forms of the protein are structurally similar and show immunological cross reactivity. Structural variants arise from a single gene via a complex pattern of posttranscriptional and post-translational events. Through the ability to bind cells and components of the extracellular matrix, fibronectin plays important parts in normal tissue development and turnover, wound repair, and inflammatory processes characterised by tissue remodelling. 14 The distribution of fibronectin in the rheumatoid synovium has been extensively studied using immunohistology at light and electron microscope levels.-'0 Fibronectin is a major extracellular matrix component of synovial tissue and, similar to its distribution in other tissues,4 is found to codistribute with fibrin, immature collagen, and reticulin fibres. It is also located in the perivascular connective tissue and basement membranes of capillaries and small blood vessels. Extracellular fibronectin is prominent in the synovial lining cell layer and is increased at sites of synovial cell hyperplasia, with intracellular fibronectin often evident.5 6 9 10 There is a marked increase in extracellular fibronectin particularly associated with the proliferative pannus, though there is no evidence that changes in the distribution of fibronectin are disease specific. " 12 The level of synovial fluid fibronectin in rheumatoid arthritis is increased compared with plasma levels5 7 8 13 and extracellular fibronectin is secreted by synovial cells in culture. '4 These observations strongly suggest that fibronectin is synthesised within the synovium, and that the synovial lining cells provide a source of synovial fluid fibronectin, though plasma fibronectin may also contribute a considerable amount.
To ascertain the sites of fibronectin synthesis within the synovium we used in situ hybridisation.15 Synovial biopsy samples from patients with rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, and control subjects without inflammatory disease have been investigated to evaluate possible differences in fibronectin synthesis in these patients, and to determine the source of increased synovial fluid fibronectin in patients with rheumatoid arthritis.
Patients and methods

PATIENTS
Frozen synovial biopsy samples were taken from 22 patients with rheumatoid arthritis (mean age 72 years; 14 women and eight men), 27 with osteoarthritis (mean age 66 years; 16 women and 11 men), three with ankylosing spondylitis (mean age 47 years, three men), and three control subjects without inflammatory disease (mean age 66 years, two women and one man). probe was diluted to give a concentration of 1 ng/,ul. To achieve even coverage of the hybridisation solution, coverslips were placed over the sections. Hybridisation was carried out at 37°C for approximately 16 [1] [2] [3] [4] Owing to its central roles in inflammation, tissue development, and remodelling, various studies have investigated the distribution of fibronectin in inflammatory joint tissue.512 The site of fibronectin synthesis within the synovium has been the subject of debate as different molecular forms of the protein show immunological cross reactivity. Intracellular fibronectin has been shown in synovial lining cells by immunohistochemistry at light and electron microscopic levels,5 6 9 10 and extracellular fibronectin is secreted by synovial cells in culture. 14 These results suggest that fibronectin is synthesised locally within the synovium and that the lining cells provide a source of synovial tissue and fluid fibronectin. Other studies, however, have implicated endothelial cells as the major source offibronectin in the synovium,8 and it is also possible that plasma fibronectin may contribute a significant proportion. Monoclonal antibodies have been used to differentiate between cellular and plasma forms of fibronectin, though there are questions about the potential cross reactivities of these antibodies. 23 24 To determine the sites of fibronectin synthesis within the synovium we used the technique of in situ hybridisation. As mRNA molecules are generally rapidly degraded within cells,'6 19 the demonstration of fibronectin mRNA within the synovium provides evidence of active gene transcription. Intense hybridisation signals for fibronectin mRNA were localised within the synovial lining layer of all biopsy samples studied and almost all of these cells were positive. This was consistent with the distribution of extracellular protein at this site. Owing to the high intensity and poor cellular ;. / * resolution of the signal it was not possible to quantify the proportion of positive and negative lining cells. The overall levels of fibronectin gene expression localised within the cells of the synovial lining cell layer were variable between patients. These variations did not appear to relate to the diagnosis or to the degree of underlying inflammatory cell infiltrate. Differences were not due to the relative preservation of total mRNA, which was assessed by hybridisation of serial sections with a poly d(T) probe. Comparison of different regions of the synovial lining in individual patients using frozen tissue is difficult. Only relatively small areas of tissue can be sectioned, and morphology and localisation with respect to the rest of the joint is poor. Variations in the hybridisation signal between patients may simply reflect differences in the levels of fibronectin synthesis in different areas of the synovium. To investigate this question we are currently adapting our method for application to formalin fixed, paraffin embedded tissues, allowing larger areas of tissue to be examined.
In areas of synovial lining cell hyperplasia, there was a concomitant increase in the number of cells containing fibronectin mRNA, with an associated increase in the deposition of immunoreactive fibronectin at this site. These results suggest that the overall increase in fibronectin production in the hyperplastic synovium is not due to increased levels of synthesis by individual lining cells, but that it is mediated by an increase in number of cells actively synthesising fibronectin. This increase in fibronectin synthesis is likely to be a major cause of increased synovial fluid fibronectin levels in inflammatory joint disease. Although the distribution of fibronectin mRNA and immunoreactive fibronectin is not disease specific, there is considerable evidence that fibronectin may influence the chronicity of inflammatory joint disease by providing an appropriate environment to support connective tissue proliferation and recruitment of cells to the synovium.1 12
In conclusion, we have shown the synthesis of fibronectin within cells of the synovial lining layer. These cells synthesise far higher levels of fibronectin message than subintimal endothelial and fibroblast-like cells, indicating that they are the major source of fibronectin in synovial tissue. To further our understanding of the precise part played by fibronectin in the pathogenesis of inflammatory joint disease it will be important to determine the molecular form(s) of fibronectin synthesised and secreted by synovial lining cells, and to relate these to degradation products in the synovial fluid.
